HISTOGENICS CORP — Form D

HISTOGENICS CORP of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-06. The offering totals $20.6M, of which $10.3M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Peter GreenleafDirectorDurham, NC
John JohnsonDirectorChanhassen, MN
Garheng Kong, M.D., Ph.DDirectorWaltham, MA
Peter GreenleafExecutive OfficerDurham, NC
Garheng KongDirectorSeattle, WA
Kevin RakinDirectorNew Haven, CT
Patrick O'DonnellDirectorPittsburgh, PA
Patrick O'DonnellExecutive OfficerPittsburgh, PA
Michael LewisDirectorBoulder, CO
Jonathan J LieberDirectorHouston, TX
Adam GridleyDirectorLexington, MA
Adam GridleyExecutive OfficerLexington, MA
Ramesh KumarDirectorCambridge, MA
Kevin McArdleExecutive OfficerBoston, MA
Manish B PottiDirectorMalvern, PA
Sanjay B SubramanianExecutive OfficerMalvern, PA
Suha B TaspolatogluDirectorMalvern, PA
Shankar MusunuriDirectorMalvern, PA
Shankar MusunuriExecutive OfficerMalvern, PA
Daniel B JorgensenExecutive OfficerMalvern, PA
Prabhavathi B FernandesDirectorMalvern, PA
Kristen B CastilloDirectorMalvern, PA
Kelly B BeckExecutive OfficerMalvern, PA
Uday B KompellaDirectorMalvern, PA
Rasappa B ArumughamExecutive OfficerMalvern, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-05-07D$395$395
2020-05-07D$14.3M$14.3M
2016-10-12D$30.0M$30.0M
2012-11-26D/A$58.3M$37.6M
2012-07-27D$58.0M$37.5M
2011-05-26D$34.3M

More